Intelligence Profile
Clinical Applications
Cysteamine Pantetheine Disulfide is being explored for several clinical applications based on its biochemical activities and effects observed in various trials and research studies.
Inflammatory and Oxidative Stress Conditions:
- The research outlined in "Influence of Vanin-1 and Catalytic Products in Liver During Normal and Oxidative Stress Conditions" suggests potential roles in modulating oxidative stress responses and inflammation. Specifically, Vanin-1, an enzyme influencing oxidative stress by modulating glutathione levels, may be affected by this compound. This indicates possible benefits in conditions characterized by oxidative stress.
Neurological Disorders:
- Cysteamine-Pantetheine Disulfide was studied for its potential effects on neurological disorders, such as Leigh Syndrome Spectrum (LSS) and MELAS. Although the trial targeting TBI was withdrawn, the completed study (NCT06644534) in MELAS patients suggests ongoing interest in its application for mitochondrial and neurological conditions due to its metabolic influence.
Infectious Diseases:
- A Phase 2 study (NCT05212662) was planned to investigate the compound's use in mild to moderate COVID-19, though it was ultimately withdrawn. This highlights the potential interest in its application for modulating immune responses during infections.
Lipomodulation and Endocrinology:
- Historical studies have shown that pantethine, related to cysteamine, impacts lipid metabolism and endocrine functions. Research such as "Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo" suggests benefits in managing lipid profiles, possibly reducing cardiovascular risk.
These diverse clinical explorations reflect the compound's potential versatility, although more robust clinical data is needed to establish definitive applications.
Disclaimer: This information is based on a summary of available research and clinical trials. For personalized medical advice, please consult a healthcare professional.